Medical Imaging in Malignant Liver Tumours Treatment Evaluation

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Causes, Screening and Diagnosis".

Deadline for manuscript submissions: closed (30 September 2022) | Viewed by 299

Special Issue Editors


E-Mail Website
Guest Editor
1. Grupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain
2. Área Clínica de Imagen Médica, Hospital Universitario Y Politécnico La Fe, 46026 Valencia, Spain
Interests: computational imaging, liver imaging, oncologic imaging

E-Mail Website
Guest Editor
Servicio de Radiología, Hospital Universitario Y Politécnico La Fe, 46026 Valencia, Spain
Interests: interventional radiology; liver neoplasms; oncologic imaging

Special Issue Information

Dear Colleagues,

This Special Issue will address the role of medical imaging, radiomics and deep learning (DL) in malignant liver tumor (hepatocellular carcinoma, cholangiocarcinoma and hepatic metastases) treatment allocation, treatment response prediction and time-to-event estimations. The role of current guidelines, radiomic features and DL tools will be explored in work ranging from pilot studies to evidence-based knowledge reports, with an emphasis on ablative techniques, trans-arterial chemoembolization (TACE) and trans-arterial radioembolization (TARE) therapies. New interventional procedures for malignant liver tumors will be explored. The relevance of the radiological report when evaluating the effects of these treatments will be discussed. Finally, the real-world data (RWD) approach to generating real-world evidence (RWE) will also be discussed and critically approached.

Prof. Dr. Luis Martí-Bonmatí
Dr. Daniel Pérez-Enguix
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • radiology
  • medical oncology
  • interventional radiology
  • endovascular procedures
  • liver neoplasms
  • computer-assisted image processing
  • deep learning

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop